Evidence map›Paper›PMID 15642148›Full record

ReviewArthritis research & therapy2005

Mast cells in inflammatory arthritis.

Peter A Nigrovic, David M Lee

Abstract readReview
In one paragraph

Review in Arthritis research & therapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Article
  2. Review
  3. The Function ofbioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. The Interplay between Chronic Pain, Opioids, and the Immune System.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2022
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Peter A NigrovicDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
David M Lee

Funding

Synovial Mast Cells in Inflammatory ArthritisR01AI059746 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI STEVENS, RICHARD L · 2004 to 2013
$3.3M
SYNOVIAL CADHERIN 11 AND ITS COUNTER-RECEPTORK08AR002214 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, DAVID M · 2001 to 2005
$598k
NIAID NIH HHS R01 AI059746NIAMS NIH HHS K08 AR002214
6 · The paper itself

Abstract

Mast cells are present in limited numbers in normal human synovium, but in rheumatoid arthritis and other inflammatory joint diseases this population can expand to constitute 5% or more of all synovial cells. Recent investigations in a murine model have demonstrated that mast cells can have a critical role in the generation of inflammation within the joint. This finding highlights the results of more than 20 years of research indicating that mast cells are frequent participants in non-allergic immune responses as well as in allergy. Equipped with a diversity of surface receptors and effector capabilities, mast cells are sentinels of the immune system, detecting and delivering a first response to invading bacteria and other insults. Accumulating within inflamed tissues, mast cells produce cytokines and other mediators that may contribute vitally to ongoing inflammation. Here we review some of the non-allergic functions of mast cells and focus on the potential role of these cells in murine and human inflammatory arthritis.

Indexed as

AnimalsArthritis, ExperimentalArthritis, RheumatoidAutoantibodiesAutoantigensAutoimmune DiseasesBacterial InfectionsCytokinesCytoplasmic GranulesEicosanoidsGlucose-6-Phosphate IsomeraseHistocompatibility Antigens Class IIHumansImmunization, PassiveImmunoglobulin EInflammationAutoantibodiesAutoantigensCytokinesEicosanoidsGlucose-6-Phosphate IsomeraseHistocompatibility Antigens Class III-Ak antigenImmunoglobulin EInflammation MediatorsReceptors, Antigen, T-Cell

Identifiers

PMID15642148
PMCPMC1064877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.